Mesothelioma.com Resources for Patients and their Families

Avon, California

Avon is an unincorporated coastal community in Contra Costa County, California. Located on San Francisco Bay about 19 miles northeast of Oakland, Avon was originally known as Marsh, after an early settler. Around 1912, the Associated Oil Company chose the area to build a refinery and a small factory town named Avon Village, which included a U.S. Post Office that operated until 1960.

Avon, California's manufacturing history is dominated by the petroleum refining industry, which has been known for its use of asbestos-containing materials. Asbestos exposure poses the risk of asbestos cancer for workers and their loved ones. An asbestos law firm may be able to assist you if you have been exposed to asbestos in Avon.

Asbestos Exposure at Jobsites in Avon

The Mesothelioma Cancer Alliance has compiled information obtained from a number of sources to identify the following jobsites in Avon where asbestos exposure was known to have occurred. These sites are listed below.

  • Associated Oil Refinery
  • Avon Refinery (Tosco)
  • Lyon Oil Refinery (Now Tosco)
  • Monsanto Chemical Company
  • Pacific Gas & Electric Company
  • Phillips Petroleum Company
  • Shell Oil
  • Tidewater Oil Company
  • Tidewater Refinery (Now Texaco)
  • Todd Shipyard
  • Tosco Oil
  • Tosco Refinery

Filing an Asbestos Lawsuit in Avon, California

Don’t lose your rights! If you or a loved one has been diagnosed with mesothelioma and were exposed to asbestos in California, you may be entitled to compensation. You may have limited time to file a claim. If you have been diagnosed with mesothelioma and have a pathology report in hand to support that diagnosis, you are eligible for financial assistance.

Asbestos Related News in California

CA Supreme Court Says Companies May Be Held Liable for Secondhand Asbestos Exposure

The Supreme Court of California has issued a ruling that companies can be held accountable for secondary exposure to asbestos in a worker's home.

Atezolizumab Approved for Non-Small Cell Lung Cancer Patients

PD-L1 inhibitor atezolizumab has been approved for use with chemotherapy-refractory metastatic Non-Small Cell Lung Cancer patients.

Asbestos Exposure Across the U.S.

Mesothelioma Cancer Alliance Blog

FEATURING:


January 20, 2017
Emily Walsh

The Importance of Grief Counseling for Mesothelioma Patients and Families

“Mesothelioma is a disease that comes with a grim outlook with only an average of 8% of patients who survive five years after their diagnosis. Because it has such a poor prognosis, a big part of treating mesothelioma – or any form of cancer, really – includes addressing mental impact it has on patients and their family members.”